Abstract: This session examines ethical considerations in allocating scarce medications, like Remdesivir, during the current pandemic. These include the ethical foundation for giving slightly greater priority to essential workers and the ethical foundation for an “affirmative action” approach that gives slightly greater priority to those from disadvantaged groups.
In conversation with Lisa Parker, PhD, Director of the University of Pittsburgh Center for Bioethics and Health Law, Dr. Schmidhofer will discuss these issues, beginning with a brief presentation, and then will address questions posed by the audience.
Additional information about joining the webinar will be available here.
Co-sponsored by the Mid-Atlantic Regional Public Health Training Center and the Center for Bioethics & Health Law